Inactive Instrument

Lattice Biologics Ltd. Share Price Toronto S.E.

Equities

LBL.H

CA5184101056

Medical Equipment, Supplies & Distribution

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2019 2.19M 2.98M 183M Sales 2020 2.46M 3.36M 206M Capitalization 4.74M 6.46M 396M
Net income 2019 -1M -1.36M -83.45M Net income 2020 -1M -1.36M -83.45M EV / Sales 2019 1.74 x
Net Debt 2019 2.12M 2.88M 177M Net Debt 2020 3.08M 4.19M 257M EV / Sales 2020 3.17 x
P/E ratio 2019
-1.67 x
P/E ratio 2020
-2.56 x
Employees -
Yield 2019 *
-
Yield 2020
-
Free-Float 79.69%
More Fundamentals * Assessed data
Dynamic Chart
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW